Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biologic therapy for colon cancer.
He AR, Marshall J. He AR, et al. Clin Adv Hematol Oncol. 2005 Jul;3(7):555-61. Clin Adv Hematol Oncol. 2005. PMID: 16167038 Review.
Stem cells in gastrointestinal cancers.
He AR, Mendelson J, Blake T, Mishra L, Marshall JL. He AR, et al. Dis Markers. 2008;24(4-5):217-22. doi: 10.1155/2008/154780. Dis Markers. 2008. PMID: 18525115 Free PMC article. Review. No abstract available.
Biologic therapies for advanced pancreatic cancer.
He AR, Lindenberg AP, Marshall JL. He AR, et al. Expert Rev Anticancer Ther. 2008 Aug;8(8):1331-8. doi: 10.1586/14737140.8.8.1331. Expert Rev Anticancer Ther. 2008. PMID: 18699769 Review.
Evaluation of hypertension as a marker of bevacizumab efficacy.
Ryanne Wu R, Lindenberg PA, Slack R, Noone AM, Marshall JL, He AR. Ryanne Wu R, et al. Among authors: he ar. J Gastrointest Cancer. 2009;40(3-4):101-8. doi: 10.1007/s12029-009-9104-9. J Gastrointest Cancer. 2009. PMID: 19921473 Free PMC article.
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors.
Kunz PL, He AR, Colevas AD, Pishvaian MJ, Hwang JJ, Clemens PL, Messina M, Kaleta R, Abrahao F, Sikic BI, Marshall JL. Kunz PL, et al. Among authors: he ar. Invest New Drugs. 2012 Dec;30(6):2364-70. doi: 10.1007/s10637-012-9800-3. Epub 2012 Feb 14. Invest New Drugs. 2012. PMID: 22331549 Free PMC article. Clinical Trial.
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
Pishvaian MJ, Marshall JL, Wagner AJ, Hwang JJ, Malik S, Cotarla I, Deeken JF, He AR, Daniel H, Halim AB, Zahir H, Copigneaux C, Liu K, Beckman RA, Demetri GD. Pishvaian MJ, et al. Among authors: he ar. Cancer. 2012 Nov 1;118(21):5403-13. doi: 10.1002/cncr.27526. Epub 2012 May 8. Cancer. 2012. PMID: 22570147 Free PMC article. Clinical Trial.
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.
Pishvaian MJ, Slack R, Koh EY, Beumer JH, Hartley ML, Cotarla I, Deeken J, He AR, Hwang J, Malik S, Firozvi K, Liu M, Elston B, Strychor S, Egorin MJ, Marshall JL. Pishvaian MJ, et al. Among authors: he ar. Cancer Chemother Pharmacol. 2012 Dec;70(6):843-53. doi: 10.1007/s00280-012-1969-9. Epub 2012 Sep 27. Cancer Chemother Pharmacol. 2012. PMID: 23014737 Free PMC article. Clinical Trial.
97 results